학술논문
P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM)
Document Type
article
Author
M. Dimopoulos; S. Opat; S. D’Sa; W. Jurczak; H.-P. Lee; G. Cull; R. G. Owen; P. Marlton; B. E. Wahlin; R. Garcia-Sanz; H. McCarthy; S. Mulligan; A. Tedeschi; J. J. Castillo; J. Czyz; C. Fernandez De Larrea Rodriguez; D. Belada; E. Libby; J. Matous; M. Motta; T. Siddiqi; M. Tani; M. Trneny; M. Minnema; C. Buske; V. Leblond; S. P. Treon; J. Trotman; W. Y. Chan; J. Schneider; H. Allewelt; A. Cohen; J. Huang; C. S. Tam
Source
HemaSphere, Vol 6, Pp 1048-1049 (2022)
Subject
Language
English
ISSN
2572-9241